Sara Erridge

6.3k total citations · 2 hit papers
67 papers, 3.0k citations indexed

About

Sara Erridge is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, Sara Erridge has authored 67 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 33 papers in Genetics and 18 papers in Oncology. Recurrent topics in Sara Erridge's work include Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (16 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Sara Erridge is often cited by papers focused on Glioma Diagnosis and Treatment (33 papers), Brain Metastases and Treatment (16 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Sara Erridge collaborates with scholars based in United Kingdom, Netherlands and United States. Sara Erridge's co-authors include Roger Stupp, Monika E. Hegi, Michael Weller, Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, Brigitta G. Baumert, Ian R. Whittle, Kenneth Aldape and Terri S. Armstrong and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Annals of Neurology.

In The Last Decade

Sara Erridge

63 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

2013 742 citations Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology profile →
ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma

2023 90 citations Maximilian Niyazi, Nicolaus Andratschke et al. Radiotherapy and Oncology profile →

Peers

Countries citing papers authored by Sara Erridge

Since Specialization

Citations

This map shows the geographic impact of Sara Erridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Erridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Erridge more than expected).

Fields of papers citing papers by Sara Erridge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Erridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Erridge. The network helps show where Sara Erridge may publish in the future.

Co-authorship network of co-authors of Sara Erridge

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Erridge. A scholar is included among the top collaborators of Sara Erridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Erridge. Sara Erridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proton Pump Inhibitor Use and Survival in Patients With Newly Diagnosed Glioblastoma 2025 ·JAMA Network Open ·Émilie Le Rhun, (unknown), Sara Erridge, David A. Reardon, Giuseppe Minniti, Patrick Roth, Wolfgang Wick, Burt Nabors, John H. Sampson, Warren Mason, Timothy F. Cloughesy, J.C. Reijneveld, Roger Stupp, Matthias Preusser, Thierry Gorlia, Michael Weller	0
2	Seizure prophylaxis in glioma surgery (SPRING): A multi-center, unblinded, randomized trial 2025 ·Neuro-Oncology Practice ·Michael D. Jenkinson, Helen Bulbeck, James Burns, Alasdair G Rooney, Richard Dobbie, Jade Carruthers, (unknown), Robin J. Watson, Ciara Gribben, Tomos Robinson, (unknown), Gerard Thompson, Sara Erridge, Colin Watts, Anthony G Marson, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
3	ESTRO-EANO guideline on target delineation and radiotherapy for IDH-mutant WHO CNS grade 2 and 3 diffuse glioma 2024 ·Radiotherapy and Oncology ·Brigitta G. Baumert, (unknown), Vera C. Keil, Norbert Galldiks, Ewa Iżycka‐Świeszewska, (unknown), Anca-Ligia Grosu, Giuseppe Minniti, Umberto Ricardi, F. Dhermain, Damien C. Weber, Martin J. van den Bent, Roberta Rudà, Maximilian Niyazi, Sara Erridge	1
4	“It changes everything”: Understanding how people experience the impact of living with a lower-grade glioma 2024 ·Neuro-Oncology Practice ·(unknown), (unknown), (unknown), Sophie Williams, Joanne Lewis, Pamela Gallagher, Tracy Finch, Richéal Burns, Vera Araújo‐Soares, (unknown), Linda Sharp, (unknown), Sara Erridge, (unknown), Catherine McBain	11
5	P18.39.A SEIZURE PROPHYLAXIS IN GLIOMA SURGERY (SPRING): A MULTI-CENTRE, UNBLINDED, RANDOMISED TRIAL 2024 ·Neuro-Oncology ·Michael D. Jenkinson, Helen Bulbeck, Alasdair G Rooney, Gerard Thompson, James Burns, (unknown), Luke Vale, Sara Erridge, Colin Watts, R. Grant, (unknown)	2
6	Glioblastoma and the search for non-hypothesis driven combination therapeutics in academia 2023 ·Frontiers in Oncology ·(unknown), (unknown), Sara Erridge, Geoff S. Higgins, Joelle P. Straehla, Margaret C. Frame, Tero Aittokallio, Neil O. Carragher, Daniel Ebner	8
7	ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma breakdown → 2023 ·Radiotherapy and Oncology ·Maximilian Niyazi, Nicolaus Andratschke, Martin Bendszus, Anthony J. Chalmers, Sara Erridge, Norbert Galldiks, Frank J. Lagerwaard, Pierina Navarria, Per Munck af Rosenschöld, Umberto Ricardi, Martin J. van den Bent, Michael Weller, Claus Belka, Giuseppe Minniti	90
8	Extent of MGMT promoter methylation modifies the effect of temozolomide on overall survival in patients with glioblastoma: a regional cohort study 2021 ·Neuro-Oncology Advances ·Michael T. C. Poon, (unknown), (unknown), (unknown), Colin Smith, Sara Erridge, Christopher J. Weir, Paul M. Brennan	10
9	Second surgery for progressive glioblastoma: a multi‐centre questionnaire and cohort‐based review of clinical decision‐making and patient outcomes in current practice 2021 ·Journal of Neuro-Oncology ·Paul M. Brennan, (unknown), (unknown), Giles Critchley, Benjamin Hall, Damian Holliman, Isaac Phang, Sarah Jefferies, (unknown), (unknown), Imran Liaquat, Hani J. Marcus, Simon Thomson, Lewis Thorne, (unknown), (unknown), Michael D. Jenkinson, Sara Erridge	13
10	ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM) 2017 ·Neuro-Oncology ·Anthony J. Chalmers, Garth Cruickshank, Laurence Dunn, Sara Erridge, Lisa Godfrey, Christopher Herbert, Sarah Jefferies, Juanita Lopez, Catherine McBain, Marc Pittman, (unknown), Colin Watts, (unknown), Sarah Halford	14
11	Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial breakdown → 2013 ·Journal of Clinical Oncology ·Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, (unknown), Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta	742
12	Current concepts and management of glioblastoma 2011 ·Annals of Neurology ·Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, Sara Erridge, Monika E. Hegi, Michael Weller, Roger Stupp	364
13	Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma 2010 ·Journal of Clinical Oncology ·Michael Brada, Sally Stenning, Rhian Gabe, Lindsay C Thompson, David E. Levy, R. Rampling, Sara Erridge, Frank Saran, Rao Gattamaneni, Kirsten Hopkins, (unknown), V. Peter Collins, Siow Ming Lee	178
14	Improved survival from lung cancer in British Columbia compared to Scotland—Are different treatment rates the whole story? 2008 ·Lung Cancer ·Sara Erridge, Brian Murray, Linda Williams, David Brewster, Roger J. Black, Allan Price, Nevin Murray, (unknown)	12
15	Improving Outcomes for Limited Stage Small Cell Lung Cancer Patients in Scotland with Concomitant Chemoradiation 2007 ·Clinical Oncology ·(unknown), Sara Erridge, Melanie Mackean, G.R. Kerr, J. Ironside, (unknown), A. Price	3
16	What will be the radiotherapy machine capacity required for optimal delivery of radiotherapy in Scotland in 2015? 2007 ·European Journal of Cancer ·Sara Erridge, Carrie Featherstone, (unknown), Jillian Campbell, Diane Stockton, Roger J. Black	16
17	General practitioner assessment of stage and performance status in lung cancer patients at a population level: Implications for prognosis and radiotherapy needs analyses 2007 ·Lung Cancer ·Scott Tyldesley, Tom Roques, Sara Erridge	9
18	The accuracy of meningioma grading: a 10‐year retrospective audit 2005 ·Neuropathology and Applied Neurobiology ·Joanna Willis, Colin Smith, James W. Ironside, Sara Erridge, Ian R. Whittle, Dawn Everington	151
19	Thoracic radiotherapy for limited-stage small cell lung cancer: Issues of timing, volumes, dose, and fractionation 2003 ·Seminars in Oncology ·Sara Erridge, Nevin Murray	27
20	The effect of overall treatment time on the survival and toxicity of radical radiotherapy for cervical carcinoma 2002 ·Radiotherapy and Oncology ·Sara Erridge, G.R. Kerr, (unknown), W. Duncan, Allan Price	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact